(19)
(11) EP 3 673 871 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
24.01.2024 Bulletin 2024/04

(45) Mention of the grant of the patent:
13.12.2023 Bulletin 2023/50

(21) Application number: 19208568.6

(22) Date of filing: 26.09.2011
(51) International Patent Classification (IPC): 
A61F 2/24(2006.01)
A61M 39/06(2006.01)
 A61F 2/95(2013.01)
(52) Cooperative Patent Classification (CPC):
A61F 2/2418; A61F 2002/9505; A61F 2230/0054; A61F 2/2436; A61F 2/9517; A61M 2039/0666

(54)

A TRANSCATHETER AORTIC VALVE IMPLANTATION SYSTEM

IMPLANTATIONSSYSTEM VON TRANSKATHETER-AORTENKLAPPEN

SYSTÈME D'IMPLANTATION DE VALVULE AORTIQUE TRANSCATHÉTER

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 24.09.2010 US 38693910 P
11.01.2011 US 201161431710 P
15.05.2011 EP 11004013
16.05.2011 EP 11166201
26.07.2011 EP 11006142
12.09.2011 WO PCT/EP2011/065744

(43) Date of publication of application:
01.07.2020 Bulletin 2020/27

(60) Divisional application:
23215761.0 / 4309633

(62) Application number of the earlier application in accordance with Art. 76 EPC:
16182354.7 / 3111889
11760780.4 / 2618779

(73) Proprietor: Boston Scientific Medical Device Limited
Galway (IE)

(72) Inventors:
  • LOMBARDI, Fabien
    1008 Prilly (CH)
  • ESSINGER, Jacques
    8832 Wollerau (CH)
  • DELALOYE, Stephane
    8180 Bülach (CH)
  • HEFTI, Jean-Luc
    1400 Cheseaux-Noréaz (CH)
  • MANTANUS, Luc
    1007 Lausanne (CH)
  • BIADILLAH, Youssef
    81371 Munich (DE)

(74) Representative: Peterreins Schley 
Patent- und Rechtsanwälte PartG mbB Hermann-Sack-Straße 3
80331 München
80331 München (DE)


(56) References cited: : 
WO-A1-2009/091509
WO-A2-2008/031103
 WO-A2-2006/138173
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).